vTv Therapeutics (VTVT) Misses Q1 EPS by 117c

vTv Therapeutics (NASDAQ: VTVT) reported Q1 EPS of ($1.17). Revenue for the quarter came in at $1 million.

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Linde (LIN) PT Lowered to $563 at Bernstein SocGen Group
• Incyte (INCY) Reiterated at Neutral by Cantor Fitzgerald After Management Chat